Combined effects of GSTP1 and MRP1 in melanoma drug resistance
about
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanomaInvolvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanomaPhytochemicals for the Management of MelanomaSirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathwayChemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like CellsA modular approach for integrative analysis of large-scale gene-expression and drug-response data.8-Methoxypsoralen is a competitive inhibitor of glutathione S-transferase P1-1The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts.The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes.Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants: simultaneously detecting GSTM1 and GSTT1 gene copy number and the allelic status of the GSTP1 Ile105Val genetic variant.Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patientsSensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest.The metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase.Glutathione in cancer cell deathMRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cellsPharmacotherapy of regional melanoma therapy.Regional treatment strategies for in-transit melanoma metastasis.Actin Gamma 1, a new Skin Cancer pathogenic Gene, identified by the Biological Feature-based Classification.Curcumin: A new candidate for melanoma therapy?GTSP1 expression in non-smoker and non-drinker patients with squamous cell carcinoma of the head and neck.Inhibition of human glutathione S-transferases by curcumin and analogues.Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids.RNA interference-mediated knockdown of SIRT1 and/or SIRT2 in melanoma: Identification of downstream targets by large-scale proteomics analysis.miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells.A Nitric Oxide Storage and Transport System That Protects Activated Macrophages from Endogenous Nitric Oxide Cytotoxicity.Glutathione S -transferase π: a potential role in antitumor therapy
P2860
Q21093253-2BDCD787-D3ED-43CD-B395-28E8B7692C9BQ24649754-5BC77DE3-A27E-4910-9D56-9AA8C6670970Q26766708-C42CDFC8-1363-496C-B888-E4539DC2ED64Q28468627-FC346C98-EE22-4227-ADEF-F6E75ED06278Q28547244-77F9411B-8EC7-483A-AFD2-5AC8E99949E0Q31154751-EF0CAD3F-C2CD-4C1D-A5C4-BB05008E1E0DQ34265397-97DCE7F7-5DBA-4E28-B871-48FF31C96FC6Q35009536-9807FD3A-C51E-4ADB-AC76-F6DD20BA112AQ35551957-2C9F4EE5-E36F-4C29-82C6-9E07A02092ACQ35632517-AEC88752-D4F2-4CC4-8D8B-8907EF2EFB87Q35643805-9A3D75E4-2A41-4F7E-843F-7551090BDEFCQ36103456-C571063A-C9DC-48E4-BA64-31936B8EB08FQ36613823-1AEE4900-88D8-4FA3-98EB-4F83A1061C48Q36775161-3F95E878-56A5-4D89-AEB5-8111210E3186Q36996450-59EDBBE7-02F4-4B97-B768-E6A54F25021DQ37129883-59CE3B8B-7EC8-4D49-9A5B-AA540265E599Q37268962-E274CB13-7C42-404B-B2E0-9284C04E8BF1Q37650312-61596750-DE08-4328-B5FF-F207B31DEE69Q37812815-556A1EF5-5A24-43C5-A6D3-9BECB1DEC7C8Q38431013-3EF5CD97-128C-494C-A7C0-DC46E5808F87Q38859978-EC7B02BB-3933-4D43-8C0F-1B083A6E2AACQ40089912-D513999E-BF3F-4BDB-8D5B-FD60B1A3E876Q46059073-27B7C36D-CB98-465F-933B-F9518F79C693Q46207470-BAAB7E49-FE4A-457F-AE47-4C1464601771Q47838931-0F4A4B26-7154-498E-B7C2-D53B4AF4F295Q48540173-426CC4B5-F0A7-4C72-B85A-B6EA9B67A219Q51315484-BE28C391-3D5C-4AC2-BED0-97D073F3E4B1Q58694500-A1D89DAB-57DF-4EC6-9DDF-C2D902305875
P2860
Combined effects of GSTP1 and MRP1 in melanoma drug resistance
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Combined effects of GSTP1 and MRP1 in melanoma drug resistance
@en
type
label
Combined effects of GSTP1 and MRP1 in melanoma drug resistance
@en
prefLabel
Combined effects of GSTP1 and MRP1 in melanoma drug resistance
@en
P2093
P2860
P356
P1476
Combined effects of GSTP1 and MRP1 in melanoma drug resistance
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602681
P407
P50
P577
2005-07-01T00:00:00Z